TCL Archive Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities July 28, 2000
TCL Archive Patient Advocacy: Committee To Advise NCI On Formation Of Liaison Group February 28, 1997
TCL Archive In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished February 12, 1988
TCL Archive LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter. October 17, 2008
